Introducing Twelve Converter! Real-time currency rates at your fingertips. Available on Android, iOS soon!

ALNY

321.85 USD
0.98
0.30%
Last update Jun 30, 11:58 AM EDT
Main market
Day range
320.795
327.07
Previous close
322.82999
Open
324.74
Access this stock data via API
Subscribe
Alnylam Pharmaceuticals Inc.
321.85
0.98
0.30%

Overview

Description

Alnylam Pharmaceuticals Inc. is a pioneering biotechnology company dedicated to transforming the lives of patients through RNA interference (RNAi) therapeutics. This scientific approach allows for innovative treatments that can silence genes responsible for certain diseases, offering a unique angle on genetic therapies. Alnylam's primary focus is on developing therapeutics for genetic, cardio-metabolic, hepatic infectious, and central nervous system diseases, contributing to redefining how these conditions are treated. The company's groundbreaking work in RNAi provides a platform for addressing otherwise untreatable or poorly managed medical conditions, positioning it as a leader in the biotechnology sector. With numerous collaborations, partnerships, and a growing pipeline of therapeutics, Alnylam plays a crucial role in advancing modern medicine and contributing to the evolving landscape of genetic therapeutics. Headquartered in Cambridge, Massachusetts, Alnylam underscores the critical intersection of innovation, medicine, and gene science in the financial and pharmaceutical markets.

About

CEO
Dr. Yvonne L. Greenstreet M.B.A., M.D.
Employees
2230
Address
675 West Kendall Street
Henri A. Termeer Square
Cambridge, 02142, MA
United States
Phone
617 551 8200
Website
Instrument type
Common stock
Sector
Healthcare
Industry
Biotechnology
Country
United States
MIC code
XNGS
Main market

Exchange is currently active.
Closing in 3 hours 59 minutes

12:00
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EDT, UTC-04:00).